U.S. Home Infusion Therapy Market size to exceed USD 31.4 Billion by 2034

Selbyville, DE. - U.S. home infusion therapy market was estimated at USD 13.8 billion in 2024 and is expected to grow from USD 15.1 billion in 2025 to USD 31.4 billion by 2034, at a CAGR of 8.4%, according to the latest report published by Global Market Insights Inc. 

Chronic illnesses such as cancer, diabetes, congestive heart failure, and immune deficiencies are on the rise in the U.S. Many of these conditions require long-term or recurring infusion therapies, making home infusion a more convenient and cost-effective option for patients.

Key Insights:

Market Size & Growth:

• 2024 Market Size: USD 13.8 billion
  
• 2025 Market Size: USD 15.1 billion
  
• 2034 Forecast Market Size: USD 31.4 billion
  
• CAGR (2025–2034): 8.4%
  

Regional Insights:

• Largest Market: South Atlantic
  
• Fastest Growing Market: West North Central
  
• Emerging States: Indiana, Kentucky, North Dakota, South Carolina, South Dakota, etc.
  

Key Growth Drivers:

1. Shift toward value-based healthcare: U.S. healthcare is steadily transitioning from fee-for-service to value-based care. Home infusion therapy aligns with this trend by reducing hospital admissions, shortening lengths of stay, and improving patient outcomes.
   
2. Growing aging population: An aging population leads to increased demand for long-term and complex medical care.
   
3. Advancements in infusion technology: Technological innovations such as portable infusion pumps, remote monitoring, and user-friendly drug delivery systems have made it safer and more feasible to administer infusion therapies at home, supporting broader adoption.
   
4. Rising healthcare costs and cost containment pressures: With hospital-based care being significantly more expensive, payers and providers are motivated to shift eligible treatments to lower-cost settings like the home.
   
5. Favorable insurance coverage and reimbursement policies: Private insurers, Medicare, and Medicaid have expanded coverage for home infusion therapies in recent years, following policy shifts during and after the COVID-19 pandemic.
   

Key Players:

• Vantiva led the market with over 3.3% share in 2024.
  
• Some of the top players in this market include Masimo, IDEXX Laboratories, Midmark, and ICU Medical, which together held a 50% share in 2024.

Key Challenges

1. Complex reimbursement and billing structures: Despite improvements, reimbursement for home infusion therapy remains fragmented and inconsistent.
   
2. Shortage of skilled healthcare professionals: Home infusion requires trained nurses and pharmacists who can manage complex therapies in home settings.
   
3. High upfront costs for providers: Home infusion providers must invest in specialized equipment, refrigeration for biologics, sterile compounding facilities, and trained staff.
   
4. Patient adherence and safety concerns: Issues like non-adherence to treatment schedules, improper storage or handling of drugs, and infection risks can impact outcomes and safety.
   
5. Regulatory and compliance burdens: Providers must navigate complex regulatory requirements, including those from the FDA, USP <797> and <800>, and state boards of pharmacy.
   

Browse key industry insights spread across 135 pages with 167 market data tables and figures from the report, “U.S. Home Infusion Therapy Market - By Product, By Application - Forecast, 2025 - 2034” in detail, along with the table of contents:

https://www.gminsights.com/industry-analysis/us-home-infusion-therapy-market

Rising Adoption of the Infusion Pumps Segment

The infusion pumps segment in the U.S. home infusion therapy market held a significant share in 2024, driven by the growing demand for controlled and precise drug delivery in home care settings. These devices offer convenience, safety, and automation, making them especially valuable for chronic conditions requiring long-term infusion, such as cancer or autoimmune diseases. With technological innovations focusing on portability, wireless monitoring, and integration with electronic health records, the infusion pump segment has seen a noticeable uptick in adoption.

Increasing Demand for Anti-Infectives

The anti-infectives segment generated sustainable revenues in 2024, owing to the high incidence of infections that require intravenous antibiotic treatment. This segment includes a range of therapies targeting bacterial, fungal, and viral infections, often administered to patients recovering from surgery or managing complex infections like osteomyelitis and sepsis. The convenience of receiving anti-infective therapy at home not only reduces hospital stays but also improves patient compliance.

South Atlantic to Emerge as a Lucrative Region

South Atlantic home infusion therapy market held a substantial share in 2024, fueled by a large aging population, a high prevalence of chronic diseases, and a well-established healthcare infrastructure that supports home-based services. Increasing awareness about the benefits of home infusion, along with favorable insurance coverage in this region, has further propelled market adoption.

Prominent players operating in the U.S. home infusion therapy industry include DAIWHA, TERUMO, MOOG, AMSINO, ICU Medical, BD, CONTEC, AVANOS, B. Braun, JMS, McKESSON, LEPU MEDICAL, Fresenius, ERENLER MEDIKAL, Baxter.

To strengthen their foothold in the U.S. home infusion therapy market, companies are deploying a mix of strategic initiatives focused on both organic growth and partnerships. Many players are expanding their service portfolios through the integration of advanced infusion devices and remote monitoring solutions that improve patient outcomes and operational efficiency. Acquisitions and mergers have also played a key role, allowing firms to broaden their geographic reach and gain access to established referral networks. Additionally, providers are investing in staff training, home care logistics, and compliance infrastructure to meet evolving regulatory standards. Customizing treatment plans and offering patient-centric care have further helped differentiate their services in a competitive market landscape.